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Abstract
Background: Estrogen or phytoestrogens treatment has been suggested to improve cognitive function of the
brain in postmenopausal women. However, there is lack of information on the mechanism of such treatment on
the central nervous system. The present study aimed to determine the effects of estradiol and soy germ
phytoestrogens on spatial memory performance in ovariectomized rats and to explore the underlying mechanisms
affecting the central nervous system.
Methods: Ovariectomized Sprague-Dawley rats were fed a basic diet supplemented with soy germ phytoestrogens
(0.4 g/kg or 1.6 g/kg) or 17b-estradiol (0.15 g/kg) for 12 weeks. At the end of the experiment, animals were
evaluated for their spatial learning and memory performance by the Morris Water Maze task. The expressions of
brain-derived neurotrophic factor (BDNF) and synaptic formation proteins in the hippocampal tissue were
estimated using RT-PCR and ELISA.
Results: It was found that rats supplemented with soy germ phytoestrogens or estradiol performed significantly
better in spatial memory acquisition and retention when compared to the rats fed on the control diet. Estradiol or
the high dose of phytoestrogens treatment significantly increased BDNF concentration and the mRNA levels for
BDNF and its TrkB receptors as well as the synaptic formation proteins, synaptophysin, spinophilin, synapsin 1 and
PSD-95, in the hippocampal tissue of the experimental animals. It was also found that phytoestrogens, in contrast
to estradiol, did not show any significant effect on the vaginal and uteri.
Conclusion: Soy germ phytoestrogens, which may be a substitute of estradiol, improved spatial memory
performance in ovariectomized rats without significant side-effects on the vaginal and uteri. The memory
enhancement effect may relate to the increase in BDNF and the synaptic formation proteins expression in the
hippocampus of the brain.
Background
It has been reported in the literatures that estrogen sup-
plement treatment improves memory acquisition and
retention in ovariectomized rats [1] and postmenopausal
women [2]. However, estrogen supplement increases the
risk of developing uterine and breast cancer in postme-
nopausal women [3]. Phytoestrogens supplement has
been considered to be a potential alternative treatment
without server side effects on the breast and the uterus
[4]. Phytoestrogens are a group of compounds with a
diphenolic structure similar to that of natural and syn-
thetic estrogens [5]. Phytoestrogens of all chemical
groups are widely spread in fruits, vegetables, legumes,
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soy diet rich of phytoestrogens improved working mem-
ory in the ovariectomized retired breeder rats [7]. How-
ever, there is a lack of understanding in the molecular
mechanism of phytoestrogens effects on the brain.
Brain-derived neurotrophic factor (BDNF) plays a cru-
cial role in the brain; it regulates the survival, differen-
tiation and phenotypic maintenance of various neuronal
populations [8]. It has also been reported that the sys-
tem of BDNF/tyrosine kinase receptors B (BDNF/TrkB)
is expressed in the hippocampus region of the brain and
it plays a crucial role in memory acquisition and reten-
tion [9]. BDNF improves the survival of hippocampal
neurons and restores hippocampal neurogenesis [10,11].
Our preliminary study showed that estradiol and phy-
toestrogens, genestein and daidzein increased BDNF
expression in fetal rat hippocampal neurons in vitro
(data not shown). Thus, we suspect that the action of
phytoestrogens or estradiol on the central nervous sys-
tem, particularly on its learning and memory function,
m a yb em e d i a t e db yB D N Fe x p r e s s i o n .T h eo b j e c t i v eo f
the present study was to examine the effects of dietary
supplementation of estradiol or phytoestrogens on the
spatial reference memory behavior in overiectomized
rats and its relation to BDNF and TrkB receptor expres-
sion in the hippocampal region of the brain. As synaptic
formation in the hippocampus plays an important role
in learning and memory function of the brain [12], the
effects of dietary supplementation of estradiol or phy-
toestrogens on hippocampal gene expression of various
synaptic formation proteins were also examined.
Methods
Animal experiment
The experimental protocol was approved by the animal
ethic committee of the University of Hong Kong
(approval code: 1072-05). Twenty-eight female Sprague-
Dawley rats aged 3 months were obtained from the
Laboratory Animal Unit of the University of Hong
Kong. All animals received a surgical operation to
remove both ovaries under general anaesthesia of intra-
peritoneal injection of ketamine (60 mg/kg, Sigma,
USA) and xylazine (10 mg/kg, Sigma, USA). After eigh-
teen days of recovery, the ovariectomized rats were ran-
domly segregated into four treatment groups (n = 7).
Animals in one group were maintained on the control
diet (Table 1) for 12 weeks. Animals in the remaining
three groups were maintained on the control diet sup-
plemented with 0.15 g/kg 17b-estradiol, or supplemen-
ted with 0.4 g/kg or 1.6 g/kg soy germ phytoestrogens
respectively. The phytoestrogens was a soy germ pro-
duct (SoyLife 40%, ACATRIS, Netherlands, Batch No.
01 M/1910/4), containing 152 mg/g daidzein, 80 mg/g
glycitein and 35 mg/g genistein.
Cognitive testing with Morris Water Maze
At the end of the feeding experiment all animals were
evaluated for their spatial memory performance by Mor-
ris Water Maze (MWM) test. The swimming pool used
for the test was 190 cm in diameter and 60 cm deep.
The escape platform (100 cm
2)w a sf i x e di nap e r m a -
nent position 2 cm under the water surface during the
course of the MWM training procedure. The quadrant
housing the escape platform was defined as the target
zone. The water in the pool was made opaque with cof-
fee-mate powder to prevent the rats from seeing the
platform, and the temperature of the water was main-
tained at 22-25°C. Spatial reference cues (arrow, star,
circle, and rectangle) around the pool were remained
constant during the test. For spatial learning acquisition
test, the rats were trained in MWM for 5 consecutive
days using 3-trial-per-day regime. The rats were placed
into the pool facing the wall randomly from one of the
three starting points located in the three quadrants
except the quadrant with the platform. If the animals
failed to find the platform by the maximum period of
120 seconds, they would be gently placed on the plat-
f o r m .A tt h ee n do fe a c ht r i a l ,t h er a t sw e r ea l l o w e dt o
r e s to nt h ep l a t f o r mf o r3 0s .T h et i m e( e s c a p el a t e n c y )
and swimming distance to reach the platform were
recorded by a video camera and analyzed using the
computer software (Noldus). To assess spatial memory
retention, a probe trial was performed 1 day after the
last training trial, during which the platform was
removed from the pool, while all other factors remained
unchanged. Rats were allowed to swim for 90 s.
Vaginal smear, uterus and brain isolation
Estrous status was observed using vaginal smear per-
formed for 10 consecutive days from the first day of the
11
th week of the feeding experiment. Vaginal smears
were obtained by flushing the rats’ vagina with 0.2 ml
0.9% saline with a blunt-end tip. The resulting
Table 1 The composition of the control diet based on the
formula of AIN-93G purified diet
Ingredient Concentration (g/kg)
Casein 200
L-cystine 3
Corn starch 397.486
Maltodextrin 132
Sucrose 100
Corn oil 70
Cellulose 50
Mineral-mix (AIN-93G-MX) 35
Viramin-mix (AIN-93G-VX) 10
Choline Bitartrate 2.5
t-Butylhydroquinone (TBHQ) 0.014
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slip and examined with a microscope.
After completion of the spatial memory tests, the ani-
mals were euthanized. The brains were rapidly removed
and placed on ice. The hippocampus were then isolated,
frozen in liquid nitrogen and stored at -80°C.
The uterus of each animal was removed and weighted,
and then fixed in 10% buffered formalin for 48 h. The
right side of the proximal region of each uterus was
embedded in paraffin wax, and 5 μm cross tissue sec-
tions were stained with hematoxylin and eosin (H&E)
for histological evaluation.
BDNF extraction and assay
The extraction of BDNF from the hippocampal tissue
was performed on ice and following the description of
Szapacs [13]. In brief, the tissue was suspended in 5
volume of lysis buffer containing 137 mM NaCl, 20 mM
Tris-HCl, 1% NP40, 10% glycerol, 1 mM PMSF, 0.5 mM
sodium vanadate and protein inhibitor cocktail (Calbio-
chem, USA). The suspension was homogenized on ice
for 20 s using a sonicater at power level 3 and pulses at
1 s. The homogenates were then centrifuged at 16000×g
for 30 min at 4°C. The resulting supernatant was stored
at -80°C for further analyses.
Mature BDNF was measured using a sensitive two-
side ELISA kit (BDNF-Emax ImmunoAssay system, Pro-
mega) following the manufacturer’s instructions. In
brief, 96-well ELISA plates were coated with 100 μl/well
of anti-BDNF monoclonal antibody and incubated over-
night at 4°C. Following wash with the washing buffer
containing 0.05% (v/v) Tween 20, 20 mM Tris-HCl, and
150 mM NaCl, pH 7.6, the plate was incubated for 1 h
with 200 μl/well of block & sampleb u f f e rt op r e v e n t
non-specific binding. The plate was washed again and
100 μl/well of samples or standard (0-500 pg rhBDNF/
ml) was added to the plate in duplicates followed by
incubation with shaking for 2 h. After washing, 100 μl/
well of anti-human BDNF antibody (1 μg/ml) was added
followed by 2 h incubation withs h a k i n g .A f t e rw a s h i n g
again, 100 μl/well of Anti-IgY HRP was added followed by
1 h incubation with shaking. After the last washing, 100
μl/well of tetramethylbenzidine solution was added fol-
lowed by 10 min incubation with shaking. The enzymatic
reaction was stopped by addition of 100 μl/well of 1N
HCl. The absorbance of the reaction product was mea-
sured within 30 min at 450 nm using a micro-plate reader.
The concentration of BDNF in the samples was calculated
from the rhBDNF standard curve by linear regression ana-
lysis performed on each micro-plate, and the BDNF were
expressed as pg of BDNF per mg protein. The total BDNF
in the sample was measured after the transient acidifica-
tion treatment of the sample below pH3.
Quantification of mRNA expression for BDNF and its
receptor TrkB and various synaptic formation proteins
Reverse transcription polymerase chain reaction (RT-
PCR) was used to evaluate the mRNA levels for BDNF
(NM012513), TrkB (NM012731), synaptotagmin 1
(NM001033680), synaptophysin (NM012664), synapsin 1
(X04655), PSD-95 (N96853) and spinophilin
(AF016252). The mRNA for GADPH (NM017008) was
used as an internal control. Primers specific to target
genes were designed from public sequences using Pri-
mer 3 software http://fokker.wi.mit.edu/primer3/input.
htm. Sequences of PCR primers were shown in Table 2.
Table 2 Sequences of PCR primers and conditions of PCR amplification of cDNA
Conditions of PCR amplification of cDNA
Primer name Sequences Products (bps) Tm length OD’s Denaturation Annealing Extension Cycles
GAPDH forward gggtgtgaaccacgagaaat 481 47 20 11 94°C for 30 s 55°C for 30 s 68°C for 35 s 33
GAPDH reverse ggaagaatgggagttgctgt 47 20 10.1
BDNF forward tgtgacagtattagcgagtgggt 219 59.1 23 5 94°C for 30 s 50°C for 30 s 68°C for 15 s 40
BDNF reverse cgattgggtagttcggcatt 60 20 5
TrkB forward cttatgcttgctggtcttgg 503 47 20 10.4 94°C for 30 s 59°C for 60 s 72°C for 35 s 38
TrkB reverse gggtattcttgctgctctca 47 20 9.4
Synaptophysin forward catcttcgcctttgctacg 508 46 19 10.8 94°C for 30 s 55°C for 30 s 68°C for 35 s 40
Synaptophysin reverse cactgaggtgttgagtcctga 49 21 8.8
synaptotagmin 1 forward gttgcggtccttttagtcgt 496 47 20 9.3 94°C for 30 s 55°C for 30 s 68°C for 35 s 33
synaptotagmin 1 reverse agtcatacacagccatcacca 47 21 9.6
synapsin 1 forward agcagcacaacataccctgtag 459 50 22 12.3 94°C for 30 s 52°C for 30 s 68°C for 35 s 40
synapsin 1 reverse gaccacaagttccacgatga 47 20 7.7
PSD-95 forward gccctgtttgattacgaca 492 44 19 8.2 94°C for 30 s 55°C for 30 s 68°C for 35 s 40
PSD-95 reverse gaacttgtgtgcctggatgt 47 20 8.7
spinophilin forward gaggaaagtggggagtctga 510 48 20 8.2 94°C for 30 s 58°C for 30 s 72°C for 35 s 37
spinophilin reverse ctcattgcgtcggtcatagt 47 20 7.8
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Protein Mini Kit (Qiagen, USA). The concentration and
purity of RNA were measured by the optical density at
260 and 280 nm using spectrophotometer (Bio-Rad).
Reverse transcription (RT) reactions were performed in
duplicates with SuperScript™ III First-strand Synthesis
SuperMix (Invitragen, USA). PCR was performed with 1
μlo fc D N Ai n2 5μl reaction mixture containing 2.5 μl
of 10× AccuPrimer™ PCR Buffer II, 0.5 μlp r i m e rm i x
(10 μM each), 0.5 μl AccuPrimer™ Taq DNA Polymerase
(Invitrogen, cat.No.12339-016, USA). The conditions of
PCR amplification of cDNA were shown in Table 2.
Finally, 5 μl of the PCR products was resolved by 1%
agarose gel electrophoresis, stained with SYBR® Safe
DNA gel stain (Invitrogen, USA) and visualized under
UV light. The density of the PCR products was analyzed
b yQ u a n t i t yO n es o f t w a r e( B i o - R a d ,U S A ) .Q u a n t i t yo f
the expressed BDNF mRNA was analyzed based on a
gray value, and expressed as the ratio of the sample den-
sity to GAPDH density amplified from an identical RNA
sample.
Statistical analysis
Data are presented as the mean ± standard error of the
mean (SEM). All data were evaluated for equality of var-
iance before statistical analysis. Statistical analysis of
experimental data was carried out using software SPSS
v15.0 (USA). Statistical differences were determined by
one-way or two-way ANOVA followed by Student-New-
man-Keuls post hoc test. Differences were considered
significant when p < 0.05.
Results
Body weight gain
T h e r ew a sn od i f f e r e n c ei nt h ei n i t i a lb o d yw e i g h t s
among the four groups of animals. During the experi-
mental period, rats in the control group and those in
the group supplemented with low dose of phytoestro-
gens gained body weight steadily and followed the simi-
lar growth pattern. Rats in the group supplemented with
high dose of soy germ phytoestrogens gained much less
weight, while rat in the group supplemented with estra-
diol gained nearly no weight during the experimental
period. By the end of the feeding experiment rats in the
control group and in the groups supplemented with low
dose of phytoestrogens, or high dose of phytoestrogens
or estradiol treatment gained (96.28 ± 13.63)g, (89.15 ±
11.9)g, (48.67 ± 14.13)g and (2.10 ± 11.38)g of body
weight, respectively.
Uterine weight uterine morphologic characteristics and
vaginal smear
The average weight of the uteri from the rats treated
with estradiol was (0.56 ± 0.04)g, which was significantly
greater than the weight from the control animals ((0.10
± 0.01)g, p < 0.05). The average uterus weights of rats
received the low or high dose of phytoestrogens treat-
ment were (0.12 ± 0.01)g and (0.14 ± 0.01)g respectively,
and they did not significantly differ from that of the
controls.
Representative vaginal smears of experimental animals
were shown in Figure 1. The smear examination for the
consecutive 10 days showed no estrus cycle in rats on
Figure 1 Representative photomicrographs of vaginal smears. The four groups of smears were performed in rats fed on the control diet (A),
and on the diet supplemented with 0.4 g/kg phytoestrogens (B), 1.6 g/kg phytoestrogens (C) or 0.15 g/kg 17bestradiol (D). The length of the
scale bar equals 250 um.
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or high dose of phytoestrogens. The vaginal smear of
these animals showed mainly leukocytes and a few irre-
gularly shaped cornified epithelial cells. In contrast, the
smear from the animals supplemented with estradiol
showed preponderance of large, irregularly noncornified
epithelial cells.
The uterine histological characteristics of experimental
animals were shown in Figure 2. In the control rats, the
uterus appeared atrophic. The endometrium was com-
posed of cuboidal inactive cells, and the connective tis-
sue showed unorganized round nuclei. No mitotic
activity was detected in epithelial cells. Similar morpho-
logic characteristics were observed in the uterus of rats
receiving low dose of phytoestrogens. In rats receiving
high dose of phytoestrogens, endometrial cells of the
uterus were stimulated but no pathologic signs were
detected. However, in rats receiving estradiol treatment,
endometrial mitotic activity was found, and all uterine
structures were hypertrophic and hyperplastic.
Behavioural Performance
To assess spatial learning acquisition, animals were
trained with 3 trials per day for 5 consecutive days on
the MWM task. The differences in escape latency (time
to find the platform) and swimming distance of each
training day among the four treatment groups were ana-
lyzed by two-way repeated measures ANOVA. On the
first day of training, no difference was found in escape
l a t e n c ya m o n gt h ef o u rg r o u p s .T h ee s c a p el a t e n c yg r a -
dually declined over the training period for all groups
(Figure 3), indicating a gradual spatial memory acquisi-
tion in all experimental animals. Statistical analysis of
two-way ANOVA (4 groups × 5 days) with repeated
measures showed significant differences between the
days of training (F = 40.47, p < 0.001) and among the
treatment groups (F = 5.329, p = 0.002). There was also
a significant interaction between the days of training
and the treatments (F = 2.558, p = 0.046). On the 5
th
day of training the escape latency of rats received the
high dose of phytoestrogens or estradiol treatment was
significantly shorter than that of the controls (p < 0.05,
Figure 3).
A similar trend was observed in the swimming dis-
tance taken by rats to locate the platform. The distance
reduced gradually for all animals over the training per-
iod (Figure 3). Statistical analysis of two-way ANOVA (4
groups × 5 days) with repeated measures showed signifi-
cant differences between the days of training (F =
45.942, p < 0.001), and among the treatment groups (F
= 3.008, p = 0.036) with a significant interaction
between the training time and the treatment (F = 3.063,
Figure 2 Representative photomicrographs of uteri. The four groups of photomicrographs come from rats fed on the control diet (A), and
on the diet supplemented with 0.4 g/kg phytoestrogens (B), 1.6 g/kg phytoestrogens (C) or 0.15 g/kg 17bestradiol (D). The length of the scale
bar equals 250 um.
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th day of training the swimming dis-
tance of rats received the high dose of phytoestrogens or
estradiol treatment was significantly shorter than that of
the controls (p < 0.05, Figure 3).
There was no significantly difference in the swimming
speed among the treatment groups at the end of 5 day
training (Figure 3). Statistical analysis showed that the
swimming speed was negatively correlated with the
body weight gains during the 12 weeks of feeding
experiment (r = -0.230, p < 0.001).
The results of the probe tests are presented in Figure 4.
All animals showed a trend of spending more time in the
Figure 3 Escape latency (A), swimming distance (B) and
swimming speed (C) over the training period. The animals were
fed on the control diet (black diamond), or the control diet
supplemented with 0.4 g/kg phytoestrogens (black square), 1.6 g/kg
phytoestrogens (black triangle), or 0.15 g/kg 17bestradiol (white
square) for 12 weeks. At the end of the experiment all animals were
evaluated for their spatial memory performance with the Morris
Water Maze task with a regime of 3 trials per day for 5 consecutive
days. The data were presented as the means with the standard
error bars (n = 7). Two-way ANOVA analysis showed significant
differences in escape latency between different training days (F =
40.47, p < 0.001) and among treatment groups (F = 5.329, p < 0.01)
with a significant interaction between the training time and the
treatment (F = 2.558, p < 0.05). The analysis also showed significant
differences in swimming distance between training days (F =
45.942, p < 0.001) and among treatment groups (F = 3.008, p <
0.05) with a significant interaction between the training time and
the treatment (F = 3.063, p < 0.05). a, b: The mean values labelled
with different letters differed significantly (p < 0.05). Significant
differences from the mean values of the control on the same
training day was indicated by * (p < 0.05).
Figure 4 Relative time spent and distance travelled in each of
the quadrants in the probe test. (A) Relative time spent, (B)
relative distance. The four quadrants of the swimming pool were
the target quadrant (dark grey), the quadrant clockwise adjacent to
the target quadrant (white), the quadrant anticlockwise adjacent to
the target quadrant (grey spotted), and the quadrant opposite to
the target quadrant (white spotted). The experimental animals were
fed for 12 weeks on the control diet (Control), or diet
supplemented with 0.4 g/kg phytoestrogens (Low-phyto), 1.6 g/kg
phytoestrogens (High-phyto) or 0.15 g/kg 17b-estradiol (Estradiol).
The probe test was performed 1 day after the last training trial.
During the probe test the platform was removed from the pool
while all other conditions remained the same as in the training
trails. Values are means with their standard errors represented by
vertical bars (n = 7). Significant differences from the mean values of
the target quadrant in each group were indicated by *(p < 0.05); **
(p < 0.001).
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phytoestrogens or estradiol treatment, the relative time
spent and distance travelled in the target quadrant were sig-
nificantly greater than those in other quadrants (p < 0.05).
Effects of estradiol and phytoestrogens treatment on
BDNF and its TrkB receptor gene expression and
expression of genes of synaptic formation proteins
In the hippocampal tissue, BDNF was detected by a spe-
cific ELISA assay. The levels of both total BDNF and its
mature form were significantly higher in animals
received phytoestrogens or estradiol treatment when
compared with that in control animals (F = 5.162, p <
0.05; F = 10.551, p < 0.05; Figure 5). The mature BDNF
contributed about 20-22% of the total BDNF, and there
was no significant difference among the four treatment
groups in the conversion of pro-BDNF to mature BDNF.
In accordance with the significant effects on BDNF
levels, phytoestrogens or estradiol treatment increased
BDNF gene expression (Figure 6). Compared with that
of control animals, the BDNF mRNA level was signifi-
cantly greater in the hippocampal tissue of the animals
treated with estradiol or high dose of soy germ phytoes-
trogens (F = 3.469, p < 0.05). The level of BDNF mRNA
was greater in the hippocampal tissue of the animals
received low dose of phytoestrogens, although not sig-
nificant, than that of control animals (Figure 6).
The mRNA level of TrkB, the primary receptor of
BDNF, was also significantly greater in the hippocampal
tissue of animals received estradiol or high dose of phy-
toestrogens treatment compared with that of the control
animals (F = 3.244, p < 0.05).
Synaptic formation plays an important role in learning
and memory function of the brain. Figure 7 presents the
relative expression levels of genes of various proteins
related to synaptic formation in the hippocampal tissue
of the experimental animals. The data showed that the
mRNA levels of synaptophysin, synapsin 1 and spinophi-
lin were significantly increased in rats received estradiol
or high dose of soy germ phytoestrogens treatment
when compared with that of the control animals (F =
3.557, p < 0.05; F = 3.453, p < 0.05; F = 3.363, p < 0.05).
The mRNA level of PSD-95 was significantly increased
in rats received estradiol treatment compared with that
of the control animals (F = 3.284, p < 0.05). No differ-
ence in mRNA level of synaptotagmin 1 was observed
among the treatment groups.
Discussion
It has been reported that estrogen replacement therapy
improves learning and memory function of the brain in
ovariectomized aged rats [1] and postmenopause women
[2]. However, estrogen treatment often has severe side
effects and may increases the risk of uterine or breast
cancer [3]. There have been wide interests in searching
for alternative compounds, and phytoestrogens have
been considered as potential candidates.
To evaluate the effect of estradiol and soy germ phy-
toestrogens on memory function, the spatial learning
acquisition and memory retention of rats were tested
using the Morris water maze (MWM) [14]. This task is
based upon the premise that animals have evolved an
optimal strategy to explore their environment and
escape from the water with a minimum amount of
effort, i.e., swimming the shortest distance possible. For
spatial learning acquisition test, the time (escape
latency) and swimming distance to reach the platform
were recorded for each rat. To assess spatial memory
retention, a probe trial was performed, during which the
platform was removed from the pool, and the percen-
tage of time spent in each quadrant was calculated and
their swim paths were recorded by a video tracking sys-
tem. The present study demonstrated that soy germ
phytoestrogens, as well as estradiol, improved spatial
learning and memory in ovariectomized rats. It was
observed that, when compared to the animals fed on the
control diet, rats fed on the diet supplemented with 1.6
g/kg soy germ phytoestrogens or 0.15 g/kg estradiol
spent significantly shorter time to find the hidden plat-
form (escape latency) during the Morris water maze
training. Although the reduction in escape latency may
partially result from the improved swimming speed, the
same animals took significant shorter swimming dis-
tance to find the hidden platform than did the control
animals (Figure 3). It was further showed that ovariecto-
mized rats received the phytoestrogens or estradiol
Figure 5 The levels of total and mature BDNF in the
hippocampal tissue of ovariectomized rats. The levels (Mean ±
SEM, n = 7) of total and mature BDNF in the hippocampal tissue of
ovariectomized rats fed on the control diet (white), or the control
diet supplemented with 0.4 g/kg phytoestrogens (white spotted),
1.6 g/kg phytoestrogens (grey spotted), or 0.15 g/kg 17b-estradiol
(dark grey). The mean values labelled with different letters differed
significantly (p < 0.05).
Pan et al. Nutrition & Metabolism 2010, 7:75
http://www.nutritionandmetabolism.com/content/7/1/75
Page 7 of 11treatment had stronger spatial bias in the probe test
than the controls (Figure 4). These findings suggest that
dietary supplementation of phytoestrogens or estradiol
improved memory acquisition and retention in ovariec-
tomized rats. Similar findings have also been reported in
the literature. Xu et al [15] reported that estradiol or
genistein treatment given by subcutaneous injection
reduced the escape latency of ovariectomized rats in a
behavioral test. Estradiol or soy phytoestrogens treat-
ment enhanced hippocampal-dependent spatial working
memory in female mice [16] and ovariectomized retired
breeder rats [17]. In postmenopausal women, dietary
supplementation of soya isoflavones for 12 weeks signifi-
cantly improved cognitive functions of the brain includ-
ing learning rule reversals and planning task [18].
In contrast to the estradiol treatment, dietary supple-
mentation of phytoestrogens showed no significant
effect on the vaginal and uteri. Vaginal smear showed
an estrus status in animals treated with estradiol but not
in animals treated with control diet or phytoestrogens
(Figure 1). We also found that estradiol, but not phy-
toestrogens, significantly increased the weight of uterus
and stimulated cell proliferation in the uterus endome-
trium (Figure 2). Our data was supported by the report
that daily treatment of genistein at 500 mg/kg(body
weight) had no estrogenic effect in the uterus or the
mammary gland in rats [19]. These findings indicate
that dietary supplementation with phytoestrogens may
have the benefit of improving cognitive function of the
brain but without the severe side effect on the reproduc-
tive tract.
Although the findings of the present study and various
earlier reports indicated that phytoestrogens or estradiol
treatment has a beneficial effect on the brain cognitive
function, how these compounds act on the brain is not
clear. Consistent with Simpkins’ [20] and Pan’s[ 7 ]
reports, we found that estradiol or phytoestrogens treat-
ment significantly increased the levels of BDNF, espe-
cially mature BDNF, in the hippocampus, the known
learning and memory centre of the brain. It was further
showed that estradiol or phytoestrogens treatment sig-
nificantly increased the mRNA levels for BDNF and its
receptor TrkB in the hippocampus (Figure 6). BDNF is
a member of the neurotrophin gene family which plays
Figure 6 The gene expression of BDNF and TrkB in the hippocampal tissue of ovariectomized rats. The gene expression of BDNF and
TrkB in the hippocampal tissue of ovariectomized rats fed on the control diet (white), or the control diet supplemented with 0.4 g/kg
phytoestrogens (white spotted), 1.6 g/kg phytoestrogens (grey spotted), or 0.15 g/kg 17bestradiol (dark grey). The upper panel showed the PCR
image and the lower panel presented the levels of BDNF and TrkB mRNA expressed as the ratio to the internal control of GADPH mRNA. The
mean values labelled with different letters differed significantly (p < 0.05).
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maintenance, and in the selective vulnerability of various
neuronal populations within the normal and diseased
brain [8]. The postsynaptic BDNF-TrkB pathway is cru-
cial for regulation of excitatory synaptic transmission
and long-term potentiation (LTP) induction, which is an
important synaptic connection model of memory forma-
tion [21]. This property implicates BDNF in the process
of learning and memory [22,23]. Moreover, neurotro-
p h i n si n i t i a l l ys y n t h e s i z e da sp r e c u r s o r s( p r o n e u r o t r o -
phins), they are cleaved to produce mature proteins,
which promote neuronal survival and enhance synaptic
plasticity by activating Trk receptor tyrosine kinases.
Recent studies indicate that proneurotrophins serve as
signalling molecules by interacting with the p75 neuro-
trophin receptor (p75NTR) which often has biological
effects that oppose those of mature neurotrophins.
Therefore, the proteolytic cleavage of proneurotrophins
represents a mechanism that controls the direction of
action of neurotrophins[24]. Although Murphy et al [25]
found estrogen treatment temporally reduced BDNF in
hippocampal cultures within 24 h of exposure, estrogen
and/or phytoestrogens finally increased BDNF expres-
sion after certain period of culture. Indeed, it has been
evidenced that estradiol regulated neurotrophins expres-
sion including BDNF [20,26-30]. Our study indicated
that to observe the effect of phytoestrogens treatment,
an effective period should be consider in the studies of
both in vivo and in vitro. On the other hand, phytoes-
trogens might show different performance in vivo base
on the gonadal hormones states. For the female, espe-
cially the peri-menopause with estrogen reducing, phy-
toestrogens will play a beneficial or substitute effect.
Synaptic formation plays an important role in the cog-
nitive function of the brain. Synaptic loss is considered
to be a reliable index of impaired cognition in dementia
[31]. The present study demonstrated that estradiol or
phytoestrogens treatment significantly increased the
expression of genes of various proteins related to synap-
tic formation in the hippocampus. Dietary supplement
Figure 7 The gene expression of sypnatic formation proteins in the hippocampal tissue of ovariectomized rats. The gene expression of
sypnatic formation proteins in the hippocampal tissue of ovariectomized rats fed on the control diet (white), or the control diet supplemented
with 0.4 g/kg phytoestrogens (white spotted), 1.6 g/kg phytoestrogens (grey spotted), or 0.15 g/kg 17bestradiol (dark grey). The upper panel
showed the PCR image and the lower panel presented the levels of mRNA of sypnatic formation proteins expressed as the ratio to the internal
control of GADPH mRNA. The mean values labelled with different letters differed significantly (p < 0.05).
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Page 9 of 11of 0.15 g/kg estradiol or 1.6 g/kg phytoestrogens signifi-
cantly increased the mRNA levels of synaptophysin,
synapsin 1, PSD-95 and spinophilin in the hippocampus
tissue (Figure 7). Synaptophysin, synaptotagmin 1 and
synapsin 1 are belong to the presynaptic vesicle proteins
which play an important role in synaptic plasticity and
cognitive function [32]. Loss of the synaptophysin in
hippocampus correlates with cognitive decline in Alzhei-
mer’s disease [33]. PSD-95 and spinophilin belongs to
postsynaptic proteins involved in synapse stabilization
and plasticity [34]. It is suspected that increased expres-
sion of genes of synaptic proteins may be partially
responsible for the improved learning and memory per-
formance following dietary supplementation of estradiol
or phytestrogens in ovariectomized rats.
Conclusions
In summary, the present study showed that phytoestro-
gens or estradiol treatment improved spatial memory
acquisition and retention in ovariectomized rats. Unlike
estradiol, phytoestrogens had no significant effect on the
reproductive system. These finding suggest that phytoes-
trogens may be used in postmenopause women to
improve cognitive function of the brain without the
severe risk of developing uterus or breast cancer. The
present study further showed that the increased gene
expression for BDNF and its receptor TrkB and for var-
ious proteins related to synaptic formation in the hippo-
campus may be partially responsible for the improved
spatial learning and memory performance in ovariecto-
mized rats following dietary supplementation of estra-
diol or phytoestrogens.
List of abbreviations
BDNF: brain-derived neurotrophic factor; p75NTR: p75 neurotrophin receptor;
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